amphotericin B

E556051

Amphotericin B is a broad-spectrum antifungal medication primarily used to treat severe, systemic fungal infections.

All labels observed (1)

Label Occurrences
amphotericin B canonical 4

How this entity was disambiguated

Statements (50)

Predicate Object
instanceOf antifungal agent ⓘ
medication ⓘ
polyene antifungal drug ⓘ
canBeCombinedWith flucytosine ⓘ
combinedWithFlucytosineUsedFor induction therapy of cryptococcal meningitis ⓘ
derivedFrom Streptomyces nodosus ⓘ
linked to: Streptomyces
discoveredBy Squibb Institute for Medical Research ⓘ
hasAdverseEffect anemia ⓘ
fever and chills ⓘ
hypokalemia ⓘ
infusion-related reactions ⓘ
nephrotoxicity ⓘ
hasATCCode J02AA01 ⓘ
hasBioavailability very low oral bioavailability ⓘ
hasBlackBoxWarning should be used primarily for progressive, potentially life-threatening fungal infections ⓘ
hasCASNumber 1397-89-3 ⓘ
hasChemicalFormula C47H73NO17 ⓘ
hasEffect causes leakage of intracellular contents of fungi ⓘ
fungicidal or fungistatic depending on concentration and organism ⓘ
hasMechanismOfAction binds to ergosterol in fungal cell membranes ⓘ
forms pores in fungal cell membranes ⓘ
hasMolarMass 924.08 g/mol ⓘ
hasProteinBinding >90% ⓘ
hasRouteOfAdministration intrathecal ⓘ
intravenous ⓘ
oral ⓘ
topical ⓘ
hasSpectrumIncludes Aspergillus species ⓘ
Blastomyces dermatitidis ⓘ
Candida species ⓘ
linked to: Candida albicans

Coccidioides species ⓘ
Cryptococcus neoformans ⓘ
Histoplasma capsulatum ⓘ
Mucorales ⓘ
isAdministeredFor severe systemic mycoses ⓘ
isBroadSpectrumAgainst fungi ⓘ
isFormulatedAs colloidal dispersion amphotericin B ⓘ
conventional deoxycholate formulation ⓘ
lipid complex amphotericin B ⓘ
liposomal amphotericin B ⓘ
isListedOn World Health Organization Model List of Essential Medicines ⓘ
isNotAbsorbedFrom gastrointestinal tract when given orally ⓘ
isOftenUsedAs initial induction therapy for serious fungal infections ⓘ
liposomalFormulationsHaveProperty reduced nephrotoxicity compared with conventional formulation ⓘ
usedForTreatmentOf aspergillosis ⓘ
cryptococcal meningitis ⓘ
invasive candidiasis ⓘ
mucormycosis ⓘ
systemic fungal infections ⓘ
visceral leishmaniasis ⓘ

How these facts were elicited

Referenced by (4)

Full triples — surface form annotated when it differs from this entity's canonical label.

Sporothrix → alternativeTreatment → amphotericin B ⓘ
Candida albicans → isTreatedWith → amphotericin B ⓘ
Leishmania donovani → drugSusceptibility → amphotericin B ⓘ
Naegleria fowleri → treatmentOption → amphotericin B ⓘ